Abstract
The effect of vanadium treatment on insulin-stimulated glucose transporter type 4 (GLUT4) translocation was studied in cardiac tissue of streptozotocin (STZ)-induced diabetic rats by determining the subcellular distribution of GLUT4. Four groups of rats were examined: control and diabetic, with or without bis(maltolato)oxovanadium(IV) (BMOV, an organic form of vanadium) treatment for 8 weeks. The effect of vanadium on insulin-induced GLUT4 translocation was studied at 5 min as the early insulin response and at 15 min after insulin injection as the maximal insulin response.
At 5 min after insulin injection, plasma membrane GLUT4 level in the diabetic-treated group was not different from the control groups and was significantly higher than that of the insulin-stimulated diabetic group, indicating an enhancement of insulin response on GLUT4 translocation brought about by vanadium treatment. In contrast to that at 5 min after insulin injection, no significant difference in the plasma membrane GLUT4 level was observed between the diabetic and the diabetic-treated groups at 15 min after insulin injection. GLUT4 mobilization from the intracellular pool in response to insulin was also investigated at 15 min after insulin injection. Basal intracellular GLUT4 content was significantly higher in the diabetic-treated group when compared to the diabetic group under the same condition. However, the increased basal intracellular GLUT4 in the diabetic-treated group did not result in more insulin-mediated GLUT4 translocation at 15 min after insulin injection. In conclusion, the finding that plasma membrane GLUT4 in the diabetic-treated group is significantly higher than that of the diabetic group at 5 min but not at 15 min post-insulin injection indicates that vanadium treatment enhances insulin-mediated GLUT4 translocation in cardiac tissue by enhancing its early response.
Similar content being viewed by others
References
Wall SR, Lopaschuk GD: Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochem Biophys Acta 1006: 97–103, 1989
Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta 1213: 263–276, 1994
Suzuki K, Kono T: Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77: 2542–2545, 1980
Zeil FH, Venkatesan N, Davidson MB: Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37: 885–890, 1988
Sinha MK, Raineri-Maldonado C, Buchanan C, Pories WJ, Carter-Su C, Pilch PF, Caro JO: Adipose tissue glucose transporters in NIDDM. Diabetes 40: 472–477, 1991
Camps M, Castello A, Munoz P, Mongar M, Testar X, Palacin M, Zorzano A: Effect of diabetes and fasting on GLUT4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J 282: 765–772, 1992
Ramanadham S, Mongold JJ, Brownsey RW, Cros FH, McNeill JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904–H911, 1989
Brichard SM, Assimacopoulos-Jeanner F, Jeanrenaud B: Vanadate treatment markedly increased glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression. Endocrinology 131: 311–317, 1992
Mansier P, Charlemagne D, Rossi B, Preteseille M, Swynghedauw B, Lelievre L: Isolation of impermeable inside-out vesicles from an enriched sarcolemma fraction of rat heart. J Biol Chem 258: 6628–6635, 1983
Li WM, Cam MC, Poucheret P, McNeill JH: Insulin-induced Glut4 recruitment in the fatty Zucker rat heart is not associated with changes in Glut4 content in the intracellular membrane. Mol Cell Biochem 183: 193–200, 1998
Avruch J, Hoelz-Sallach DF: Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta 233: 334–347, 1971
Laemmli UK: Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Kahn BB, Charron MJ, Lodish HF, Cushman SW, Flier JS: Different regulation of two glucose transporters in adipose cells from diabetic and insulin treated diabetic rats. J Clin Invest 84: 404–411, 1989
Eckel J, Reinauer H: Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes-induced alteration. Biochem Soc Trans 18: 1125–1127, 1990
Stanley WC, Hall JL, Smith KR, Cartee GD, Hacker TA, Wisneski JA: Myocardial glucose transporters and glycolytic metabolism during ischemia in hyperglycemic diabetic swine. Metabolism 43: 61–69, 1994
Hall JL, Sexton WL, Stanley WC: Exercise training attenuates the reduction in myocardial GLUT-4 in diabetic rats. J Appl Physiol 78: 76–81, 1995
Kainulainen H, Breiner M, Schurmann A, Marttinen A, Virjo A, Joost HG: In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta 1225: 275–282, 1994
Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ: Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151–155, 1995
Strout HV, Vicario PP, Biswis C, Saperstein R, Brady EJ, Pilch PF, Berger J: Vanadate treatment of streptozotocin-diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728–2732, 1990
Kopp SJ, Daar J, Paulson J, Romano FD, Laddaga R: Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter. J Mol Cell Cardiol 29: 2355–2362, 1997
Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE: Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA 88: 7815–7819, 1991
Mountjoy KG, Flier JS: Vanadate regulates glucose transporter (GLUTl) expression in NIH 3T3 mouse fibroblasts. Endocrinology 126: 2778–2787, 1990
Meyerovitch J, Fargel Z, Sack J, Schechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem 262: 6658–6662, 1987
Yuen VG, Orvig C, McNeill JH: Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(lV). Can J Physiol Pharmacol 71: 263–269, 1993
Goldfine AB, Simonson DC, Folli F, Patti ME, Khan CR: Metabolic effects of sodium metavanadate in humans with insulin dependent and non insulin dependent diabetes mellitus in vivo and in vitro studies. Clin Endocrinol Metab 80: 3311–3320, 1995
Boden G, Chen S, Ruiz J, George DV, Rossum V, Turco S: Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non insulin dependent diabetes mellitus. Metabolism 45: 1130–1135, 1996
Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H: Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese non diabetic subjects. Diabetes 45: 695–666, 1996
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, S.H., McNeill, J.H. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Mol Cell Biochem 217, 121–129 (2001). https://doi.org/10.1023/A:1007224828753
Issue Date:
DOI: https://doi.org/10.1023/A:1007224828753